Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy variable (III)-16-1, abbreviated as IGHVIII-16-1, is a **pseudogene** in the human genome, specifically classified as a non-functional gene segment related to the variable region of the immunoglobulin heavy chain[4][6]. Unlike productive immunoglobulin heavy variable genes, this pseudogene does not encode a functional protein due to sequence alterations that prevent the generation of a productive antibody chain. As a result, it neither serves as a target for therapeutic intervention nor holds established biological functions or disease associations. It exists as part of the extensive immunoglobulin gene locus, which encodes components for antibody diversity, but this particular sequence is **non-functional** in the production of functional immunoglobulins[2][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy variable (III)-16-1 (pseudogene) (IGHVIII-16-1).